Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK.
Sci Signal
; 15(736): eabg5216, 2022 05 31.
Article
in En
| MEDLINE
| ID: mdl-35639855
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperidines
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Proto-Oncogene Proteins c-hck
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Sci Signal
Journal subject:
CIENCIA
/
FISIOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: